Arturo Molina M.D., Chief Medical Officer at Protagonist Therapeutics, Inc (PTGX), sold 1,848 shares at $16.24 ($30K) on 2023-11-15, disclosed to the SEC on 2024-01-04.
Open-market sale of $30k PTGX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PTGX | SELL | 2026-01-21 | $785K | — | Filing → |
| PTGX | SELL | 2025-11-19 | $460K | — | Filing → |
| PTGX | SELL | 2025-06-11 | $1.1M | — | Filing → |